FDA Approves Novel Gene Therapy for Rare Form of Vision Loss

Luxturna is for children and adults with a form of inherited vision loss that may lead to blindness. It is the first gene therapy approved in the United States to treat a disease caused by mutations in a specific gene.
FDA Approvals

Full Story →